New York-based hedge fund Mason Capital Management has filed a legal claim seeking at least US$175 million from the South Korean government as compensation for damages it says it sustained from a 2015 merger of two Samsung Group affiliates, reported the Financial Times.
Its action follows a similar move by US activist fund Elliott Management, which in May initiated an international legal process to seek US$670 million in compensation from Seoul over its role in the merger of Samsung C&T and Cheil Industries.
Seoul’s justice ministry said on Tuesday, July 3, that Mason Capital filed a notice of intent on June 7, seeking a resolution through the Investor-State Dispute Settlement mechanism.
The hedge fund claimed in the notice that it suffered huge losses due to Seoul’s undue influence over the decision of the country’s state-run pension fund in the merger process and Seoul’s act was in breach of South Korea’s free trade agreement with the US. The National Pension Service, a key shareholder of Samsung C&T, supported the contentious deal, blocking Elliott’s attempt against the US$8 billion merger.
Featured News
Trump Administration Steps Up Pressure On EU Digital Laws
May 18, 2025 by
CPI
Elton John Slams UK Government’s AI Copyright Plan as ‘Theft’
May 18, 2025 by
CPI
Anthropic’s Legal Team Blames AI “Hallucination” for Citation Error in Copyright Lawsuit
May 18, 2025 by
CPI
Intel Challenges €376 Million EU Antitrust Fine in Ongoing Legal Battle
May 18, 2025 by
CPI
FTC Chairman Highlights Fiscal Responsibility and Consumer Protection in House Testimony
May 18, 2025 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Healthcare Antitrust
May 14, 2025 by
CPI
Healthcare & Antitrust: What to Expect in the New Trump Administration
May 14, 2025 by
Nana Wilberforce, John W O'Toole & Sarah Pugh
Patent Gaming and Disparagement: Commission Fines Teva For Improperly Protecting Its Blockbuster Medicine
May 14, 2025 by
Blaž Višnar, Boris Andrejaš, Apostolos Baltzopoulos, Rieke Kaup, Laura Nistor & Gianluca Vassallo
Strategic Alliances in the Pharma Sector: An EU Competition Law Perspective
May 14, 2025 by
Christian Ritz & Benedikt Weiss
Monopsony Power in the Hospital Labor Market
May 14, 2025 by
Kevin E. Pflum & Christian Salas